glp-1 agonists and inflammation The anti-inflammatory feature of glucagon-like peptide-1 its based diabetes drugs—Therapeutic potential exploration in lung injury Exploring the therapeutic potential of
Description
[DOI] [PubMed] [Google Scholar] 42.Odah T., Vattikonda A., Stark M., Brahmbhatt B., Lukens F.J., Badurdeen D., Hashash J.G., Farraye F.A
The front page had me (pulled from social media) on the cover with a headline Grant said
doi: 10.1016/S0140-6736(07)61602-X
These are usually mild and resolve within days
We think thats a signal worth investigating. Ungar has studied online health discussions for years, including early efforts in 2011 to extract information about drug side effects from user-generated content
